[Animal models for inborn lysosomal storage diseases (author's transl)].
D000818:Animals; D002415:Cats; D002417:Cattle; D004195:Disease Models, Animal; D004285:Dogs; D005678:G(M2) Ganglioside / Q000378:metabolism; D005733:Gangliosidoses / Q000662:veterinary; D005776:Gaucher Disease / Q000662:veterinary; D006003:Glycogen / Q000378:metabolism; D006009:Glycogen Storage Disease Type II / Q000662:veterinary; D006020:Glycopeptides / Q000378:metabolism; D006801:Humans; D007965:Leukodystrophy, Globoid Cell / Q000662:veterinary; D007966:Leukodystrophy, Metachromatic / Q000662:veterinary; D008064:Lipidoses / Q000662:veterinary; D008247:Lysosomes / Q000378:metabolism*; D008361:Mannosidases / Q000172:deficiency; D008661:Metabolism, Inborn Errors / Q000662:veterinary*; D051379:Mice; D009542:Niemann-Pick Diseases / Q000662:veterinary; D011817:Rabbits; D013107:Sphingolipids / Q000378:metabolism*
D006020:Glycopeptides; D013107:Sphingolipids; D005678:G(M2) Ganglioside; D006003:Glycogen; D008361:Mannosidases